Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study

BACKGROUND: Recent in vitro and animal experiments suggest that peroxisome proliferation-activated receptor gamma (PPARɣ) agonist medications, such as antidiabetic glitazone (GTZ) drugs, are neuroprotective in models of Parkinson’s disease (PD). These findings have not been tested in humans. We hypo...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS Med
Huvudupphovsmän: Brauer, Ruth, Bhaskaran, Krishnan, Chaturvedi, Nishi, Dexter, David T., Smeeth, Liam, Douglas, Ian
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2015
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4511413/
https://ncbi.nlm.nih.gov/pubmed/26196151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1001854
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk